| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 19,300 | $20 | $443.9K |
| Q5126 | Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg | 4,930 | $50 | $246.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,090 | $90 | $97.2K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 970 | $90 | $85.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 520 | $100 | $51.8K |
| 77067 | The provider takes two X–ray views of each breast for routine screening and may use specially designed computer software to help identify any potential abnormalities within the images; the software… | 190 | $90 | $16.6K |
| 58571 | The provider incises all of the uterine, ovarian, and cervical connections through a laparoscope, and removes the uterus, cervix, and fallopian tubes, with or without the ovaries via the trocar ports… | 20 | $690 | $16.5K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 300 | $50 | $14.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 210 | $60 | $12.6K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 470 | $20 | $10.3K |